Archive

2009, Vol. 119, No. 10

September 01, 2009

previous issue next issue

Does stenting for atherosclerotic renovascular disease improve blood pressure and kidney function better than medical treatment?

Pierre F. Plouin, Laurence Amar

Pol Arch Intern Med. 2009, Vol. 119, No. 10: 612-613 / DOI: 10.20452/pamw.783

The effect of dialysis membrane type on plasma concentrations of pentosidine, a marker of carbonyl stress, in hemodialyzed patients

Dorota Słowik‑Żyłka, Krzysztof Safranow, Violetta Dziedziejko, Kazimierz Ciechanowski, Krzysztof Dziewanowski, Dariusz Chlubek

Pol Arch Intern Med. 2009, Vol. 119, No. 10: 614-620 / DOI: 10.20452/pamw.785

Glycemic profile and effectiveness and safety of insulin therapy in septic patients. Is the blood glucose level sufficient?

Jakub Szrama, Piotr Smuszkiewicz, Iwona Trojanowska

Pol Arch Intern Med. 2009, Vol. 119, No. 10: 621-627 / DOI: 10.20452/pamw.787

Metalloproteinases MMP‑9, MMP‑2 and their tissue inhibitors TIMP‑1, TIMP‑2 in peripheral transbronchial lung biopsies of patients with sarcoidosis

Wojciech J. Piotrowski, Agnieszka Nawrocka‑Kunecka, Adam Antczak, Jerzy Marczak, Romuald Biernacki, Piotr Kordek, Zofia Kurmanowska, Paweł Górski

Pol Arch Intern Med. 2009, Vol. 119, No. 10: 628-635 / DOI: 10.20452/pamw.789

Evidence for tissue factor expression in aortic valves in patients with aortic stenosis

Joanna Natorska, Grzegorz Marek, Marta Hlawaty, Dorota Sobczyk, Jerzy Sadowski, Wiesława Tracz, Anetta Undas

Pol Arch Intern Med. 2009, Vol. 119, No. 10: 636-643 / DOI: 10.20452/pamw.791

Should we prescribe blood pressure lowering drugs to every patient with advanced chronic kidney disease? A comment on two recent meta‑analyses

Peter Gross, Holger Schirutschke, Kerstin Barnett

Pol Arch Intern Med. 2009, Vol. 119, No. 10: 644-647 / DOI: 10.20452/pamw.793

Do α‑reductase inhibitors prevent prostate cancer? 2008 Practice Guideline from the American Society of Clinical Oncology and American Urological Association

David Thüer, David Pfister, Robin Epplen, Bernhard Brehmer, Axel Heidenreich

Pol Arch Intern Med. 2009, Vol. 119, No. 10: 648-653 / DOI: 10.20452/pamw.795

Seasonal and pandemic influenza vaccines for the elderly and other risk groups. A review of available data

Piotr Kramarz, Bruno Ciancio, Angus Nicoll

Pol Arch Intern Med. 2009, Vol. 119, No. 10: 654-659 / DOI: 10.20452/pamw.797

How to diagnose and treat work‑related asthma. Key messages for clinical practice from the American College of Chest Physicians Consensus Statement

Susan M. Tarlo, Gary M. Liss, Paul D. Blanc

Pol Arch Intern Med. 2009, Vol. 119, No. 10: 660-666 / DOI: 10.20452/pamw.799

Should we target HDL cholesterol level in lowering cardiovascular risk?

Peter P. Toth

Pol Arch Intern Med. 2009, Vol. 119, No. 10: 667-672 / DOI: 10.20452/pamw.801

Idiopathic retroperitoneal fibrosis: case report

Bartłomiej Kisiel, Robert Kruszewski, Agnieszka Jurek‑Urbanowska, Rafał Kidziński, Emilia Frankowska, Marian Sułek, Małgorzata Tłustochowicz, Romana Bogusławska‑Walecka, Witold Tłustochowicz

Pol Arch Intern Med. 2009, Vol. 119, No. 10: 677-679 / DOI: 10.20452/pamw.803

Relapsing polychondritis: case report and literature review

Krzysztof Pol, Mirosław Jarosz

Pol Arch Intern Med. 2009, Vol. 119, No. 10: 680-683 / DOI: 10.20452/pamw.805

Taurine bromamine: a new therapeutic option in inflammatory skin diseases

Janusz Marcinkiewicz

Pol Arch Intern Med. 2009, Vol. 119, No. 10: 673-676 / DOI: 10.20452/pamw.807

Impact Factor 2022

4.8

IC value for 2022

217.18

Ministry of Education and Science score

200

Average times from:
submission to 1st decision, 2 days
submission to first reviews, 23 days
acceptance to online first publication, 7 days
acceptance to final publication, 91 days

Current manuscript acceptance rate: 28%

The journal is co-financed from the state budget under the "Development of scientific journals" program of the Ministry of Education and Science in the years 2022-2024. Read more